TAAR1 and psychiatric disorder: Activation of TAAR1 inhibits midbrain dopaminergic and serotoninergic activity and enhances prefrontal glutamatergic neuron function, which has been associated with a variety of psychiatric disorders, including drug addiction, schizophrenia, and attention‐deficit hyperactivity disorder.10, 11